Company News Archives - Amphista Therapeutics

Blogs Company News

Back in the heart of protein degradation

Read our new CSOs thoughts on the protein degradation field as he takes on his new role - coming soon!

Ian ChurcherJune 27, 2020

Company News

Amphista Therapeutics appoints Ian Churcher as CSO

Glasgow, Scotland, 21 May 2020 - Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural…

adminMay 21, 2020

Company News

Amphista Therapeutics raises $7.5m Series A round

Amphista’s potent bifunctional small molecules augment targeted protein degradation Investors include Advent Life Sciences, the Scottish Investment Bank, the European…

adminApril 7, 2020

Company News

Back in the heart of protein degradation

Amphista Therapeutics appoints Ian Churcher as CSO

Amphista Therapeutics raises $7.5m Series A round

Events

Events

Categories

Quick Links

Legal

About